Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001292895 | SCV001481587 | uncertain significance | Mosaic variegated aneuploidy syndrome 2 | 2020-01-08 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Ambry Genetics | RCV002538417 | SCV003751078 | uncertain significance | Inborn genetic diseases | 2021-12-03 | criteria provided, single submitter | clinical testing | The c.233A>G (p.D78G) alteration is located in exon 3 (coding exon 3) of the CEP57 gene. This alteration results from a A to G substitution at nucleotide position 233, causing the aspartic acid (D) at amino acid position 78 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |